The latest attempt to curb drug prices would penalize pharmaceutical companies for raising prices faster than the rate of inflation.

It's a moving target--the more someone actually makes, the more they think they need to be "rich."

Despite explosive growth in investments, HSAs don't appear to have accomplished their original intent.

The number of physicians who reported telemedicine "as a skill" doubled from 2015 to 2018 and continues to increase.